HeartSciences Management
Management criteria checks 4/4
HeartSciences' CEO is Andrew Simpson, appointed in Mar 2022, has a tenure of 2.75 years. total yearly compensation is $300.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.45% of the company’s shares, worth $16.52K. The average tenure of the management team and the board of directors is 2.8 years and 3.3 years respectively.
Key information
Andrew Simpson
Chief executive officer
US$300.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 2.8yrs |
| CEO ownership | 0.4% |
| Management average tenure | 2.8yrs |
| Board average tenure | 3.3yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Oct 31 2024 | n/a | n/a | -US$8m |
| Jul 31 2024 | n/a | n/a | -US$7m |
| Apr 30 2024 | US$300k | US$300k | -US$7m |
| Jan 31 2024 | n/a | n/a | -US$6m |
| Oct 31 2023 | n/a | n/a | -US$6m |
| Jul 31 2023 | n/a | n/a | -US$6m |
| Apr 30 2023 | US$456k | US$234k | -US$6m |
| Jan 31 2023 | n/a | n/a | -US$7m |
| Oct 31 2022 | n/a | n/a | -US$7m |
| Jul 31 2022 | n/a | n/a | -US$6m |
| Apr 30 2022 | US$145k | US$26k | -US$5m |
| Jan 31 2022 | n/a | n/a | -US$4m |
| Apr 30 2021 | US$43k | n/a | -US$2m |
| Apr 30 2020 | US$50k | n/a | -US$4m |
Compensation vs Market: Andrew's total compensation ($USD300.00K) is below average for companies of similar size in the US market ($USD650.40K).
Compensation vs Earnings: Andrew's compensation has been consistent with company performance over the past year.
CEO
Andrew Simpson (55 yo)
2.8yrs
Tenure
US$300,000
Compensation
Mr. Andrew Simpson is Chairman and Chief Executive Officer of HeartSciences, Inc. Mr. Simpson serves as Chief Executive Officer of Heart Test Laboratories, Inc. since March 2022 and serves as its President...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman of the Board of Directors | 2.8yrs | US$300.00k | 0.45% $ 16.5k | |
| CFO & Treasurer | 2.7yrs | US$179.32k | 0% $ 0 | |
| COO, Secretary & Director | 2.8yrs | US$300.00k | 0.45% $ 16.8k |
2.8yrs
Average Tenure
55yo
Average Age
Experienced Management: HSCS's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman of the Board of Directors | 12.4yrs | US$300.00k | 0.45% $ 16.5k | |
| COO, Secretary & Director | 11.5yrs | US$300.00k | 0.45% $ 16.8k | |
| Independent Director | 2yrs | US$57.50k | 0% $ 0 | |
| Independent Director | 4.6yrs | US$60.00k | 0.0017% $ 63.9 | |
| Independent Director | 10.9yrs | US$57.50k | 0.0062% $ 229.9 | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
3.3yrs
Average Tenure
62yo
Average Age
Experienced Board: HSCS's board of directors are considered experienced (3.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 22:50 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HeartSciences Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Lucas Ward | Ascendiant Capital Markets LLC |
| Bruce Jackson | Benchmark Company |
| Allen Klee | Maxim Group |